Clinical Trial Update: Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Vinorelbine in unresectable or metastatic esophageal and gastric adenocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Esophageal Cancer, Gastric Cancer | Phase 2 | Status: COMPLETED